These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8373003)

  • 1. IgE and non-IgE mechanisms in ocular allergy.
    Bonini S; Bonini S
    Ann Allergy; 1993 Sep; 71(3):296-9. PubMed ID: 8373003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of IgE-dependent mast cell activation in a murine model of allergic conjunctivitis.
    Fukuda K; Ohbayashi M; Morohoshi K; Zhang L; Liu FT; Ono SJ
    J Allergy Clin Immunol; 2009 Oct; 124(4):827-33.e2. PubMed ID: 19660804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic conjunctivitis: the forgotten disease.
    Bonini S
    Chem Immunol Allergy; 2006; 91():110-20. PubMed ID: 16354953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities.
    Leonardi A; De Dominicis C; Motterle L
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):429-35. PubMed ID: 17873584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of lacrymal IgE determination and conjunctival cytology in the diagnosis of chronic conjunctivitis].
    Bourcier T; Moldovan M; Goldschild M; Becquet F; Brignole F; Goguel A; Baudouin C
    J Fr Ophtalmol; 1998 Mar; 21(3):209-13. PubMed ID: 9759406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgE-mediated hypersensitivity reactions.
    Fadal RG
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):565-78. PubMed ID: 8414585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
    Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of ocular allergy.
    Hodges MG; Keane-Myers AM
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):424-8. PubMed ID: 17873583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms in adverse reactions to food. The eye.
    Bonini S; Bonini S
    Allergy; 1995; 50(20 Suppl):68-73. PubMed ID: 7741209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.
    Macleod JD; Anderson DF; Baddeley SM; Holgate ST; McGill JI; Roche WR
    Clin Exp Allergy; 1997 Nov; 27(11):1328-34. PubMed ID: 9420138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy and asthma: distinguishing the causes from the triggers. An eye model for the study of inflammatory events following allergen challenge.
    Bonini S; Adriani E; Bonini S; De Petrillo G; Loggi GG; Adabbo A; Pani M; Balsano F
    Eur Respir J Suppl; 1989 Jun; 6():497s-501s. PubMed ID: 2803406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy.
    Sacchetti M; Lambiase A; Aronni S; Griggi T; Ribatti V; Bonini S; Bonini S
    J Allergy Clin Immunol; 2006 Oct; 118(4):872-7. PubMed ID: 17030240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical picture, diagnosis and therapy of allergic eye diseases].
    Groblewska A
    Pol Merkur Lekarski; 2003 Jun; 14(84):719-22. PubMed ID: 14524317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revised terminology for allergies and related conditions].
    Gerth van Wijk R; van Cauwenberge PB; Johansson SG
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2289-93. PubMed ID: 12497756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allergic conjunctivitis].
    Del Río-Navarro BE; Sienra-Monge JJ; Castellanos A; Williams-Gotti MJ
    Bol Med Hosp Infant Mex; 1992 Apr; 49(4):201-4. PubMed ID: 1305389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attainments in atop: special aspects of allergy and IgE.
    Milgrom H
    Adv Pediatr; 2002; 49():273-97. PubMed ID: 12214775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical cis-urocanic acid prevents ocular surface irritation in both IgE -independent and -mediated rat model.
    Jauhonen HM; Laihia J; Oksala O; Viiri J; Sironen R; Alajuuma P; Kaarniranta K; Leino L
    Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2357-2362. PubMed ID: 28840310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis.
    Komatsu N; Miyazaki D; Tominaga T; Kuo CH; Namba S; Takeda S; Higashi H; Inoue Y
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5307-13. PubMed ID: 18658092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Revised terminology for allergies and related conditions].
    Gerth van Wijk R; van Cauwenberge PB; Johansson SG
    Ned Tijdschr Tandheelkd; 2003 Aug; 110(8):328-31. PubMed ID: 12953386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.